Identification and Functional Characterization of ST3GAL5 and ST8SIA1 Variants in Patients with Thyroid-Associated Ophthalmopathy

키워드

참고문헌 (43)

1. Kuriyan AE, "The eye and thyroid disease", Curr Opin Ophthalmol, 19, pp.499~506 (2008)
2. RUNDLE FF, "Management of exophthalmos and related ocular changes in Graves’ disease", Metabolism, 6, pp.36~48 (1957)
3. Wiersinga WM, "Epidemiology and prevention of Graves’ ophthalmopathy", Thyroid, 12, pp.855~860 (2002)
4. Bahn RS, "Graves’ ophthalmopathy", N Engl J Med, 362, pp.726~738 (2010)
5. Bartalena L, "Management of Graves’ ophthalmopathy:reality and perspectives", Endocr Rev, 21, pp.168~199 (2000)
6. Liu YH, "Association of IL12B polymorphisms with susceptibility to Graves ophthalmopathy in a Taiwan Chinese population", J Biomed Sci, 19, pp.97~ (2012)
7. Liu YH, "Association of interleukin-1β (IL1B) polymorphisms with Graves’ ophthalmopathy in Taiwan Chinese patients", Invest Ophthalmol Vis Sci, 51, pp.6238~6246 (2010)
8. Niyazoglu M, "Association of PARP-1, NF-κB, NF-κBIA and IL-6, IL-1β and TNF-α with Graves disease and Graves ophthalmopathy", Gene, 547, pp.226~232 (2014)
9. Liao WL, "Toll-like receptor gene polymorphisms are associated with susceptibility to Graves’ ophthalmopathy in Taiwan males", BMC Med Genet, 11, pp.154~ (2010)
10. van Echten G, "Ganglioside metabolism. Enzymology, topology, and regulation", J Biol Chem, 268, pp.5341~5344 (1993)
11. Kook KH, "Altered ganglioside expression modulates the pathogenic mechanism of thyroid-associated ophthalmopathy by increase in hyaluronic acid", Invest Ophthalmol Vis Sci, 52, pp.264~273 (2011)
12. Kaback LA, "Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1β in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy", J Clin Endocrinol Metab, 84, pp.4079~4084 (1999)
13. Werner SC, "Classification of the eye changes of Grave’s disease", J Clin Endocrinol Metab, 29, pp.982~984 (1969)
14. Mourits MP, "Clinical activity score as a guide in the management of patients with Graves’ophthalmopathy", Clin Endocrinol (Oxf), 47, pp.9~14 (1997)
15. Lam AK, "Intra-observer and interobserver variation of Hertel exophthalmometry", Ophthalmic Physiol Opt, 29, pp.472~476 (2009)
16. Choi JH, "Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1", Pharmacogenet Genomics, 19, pp.770~780 (2009)
17. Choi JH, "A common 5’-UTR variant in MATE2-K is associated with poor response to metformin", Clin Pharmacol Ther, 90, pp.674~684 (2011)
18. Jang GH, "Functional characterization of genetic variations in the MDR3 promoter", Biochem Biophys Res Commun, 430, pp.1312~1318 (2013)
19. Tsuji S, "Molecular cloning and functional analysis of sialyltransferases", J Biochem, 120, pp.1~13 (1996)
20. Proia RL, "Gangliosides help stabilize the brain", Nat Genet, 36, pp.1147~1148 (2004)
21. Yamashita T, "Enhanced insulin sensitivity in mice lacking ganglioside GM3", Proc Natl Acad Sci U S A, 100, pp.3445~3449 (2003)
22. Yoshikawa M, "Mice lacking ganglioside GM3 synthase exhibit complete hearing loss due to selective degeneration of the organ of Corti", Proc Natl Acad Sci U S A, 106, pp.9483~9488 (2009)
23. Simpson MA, "Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3synthase", Nat Genet, 36, pp.1225~1229 (2004)
24. Fragaki K, "Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency", Eur J Hum Genet, 21, pp.528~534 (2013)
25. Husain S, "Variants of ST8SIA1 are associated with risk of developing multiple sclerosis", PLoS One, 3, pp.e2653~ (2008)
26. Ramagopalan SV, "Variants in ST8SIA1 do not play a major role in susceptibility to multiple sclerosis in Canadian families", J Neuroimmunol, 212, pp.142~144 (2009)
27. Kim SW, "Isolation and characterization of the promoter region of the human GM3 synthase gene", Biochim Biophys Acta, 1578, pp.84~89 (2002)
28. Zeng G, "Characterization of the 5’-flanking fragment of the human GM3-synthase gene", Biochim Biophys Acta, 1625, pp.30~35 (2003)
29. Chung TW, "Molecular mechanism for transcriptional activation of ganglioside GM3 synthase and its function in differentiation of HL-60 cells", Glycobiology, 15, pp.233~244 (2005)
30. Ozanne BW, "Transcription factors control invasion: AP-1 the first among equals", Oncogene, 26, pp.1~10 (2007)
31. Pfäfflin A, "Increased glucose uptake and metabolism in mesangial cells overexpressing glucose transporter 1 increases interleukin-6 and vascular endothelial growth factor production: role of AP-1 and HIF-1α", Cell Physiol Biochem, 18, pp.199~210 (2006)
32. Duane WC, "Transactivation of the human apical sodium-dependent bile acid transporter gene by human serum", J Steroid Biochem Mol Biol, 108, pp.137~148 (2008)
33. Ramírez-Sotelo G, "Regulation of the mouse Na+-dependent glutamate", aspartate transporter GLAST: putative role of an AP-1 DNA binding site, 2007, pp.32, 73~80
34. Mittelstadt ML, "AP-1 mediated transcriptional repression of matrix metalloproteinase-9 by recruitment of histone deacetylase 1 in response to interferon β", PLoS One, 7, pp.e42152~ (2012)
35. Kang NY, "Transcriptional regulation of the human GD3 synthase gene expression in Fas-induced Jurkat T cells: a critical role of transcription factor NF-κB in regulated expression", Glycobiology, 16, pp.375~389 (2006)
36. Martinez EE, "A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)", Cancer Prev Res (Phila), 7, pp.950~957 (2014)
37. Song LN, "The tumor suppressor NKX3.1 is targeted for degradation by DYRK1B kinase", Mol Cancer Res, 13, pp.913~922 (2015)
38. Solomon SS, "A critical role of Sp1 transcription factor in regulating gene expression in response to insulin and other hormones", Life Sci, 83, pp.305~312 (2008)
39. Samson SL, "Role of Sp1 in insulin regulation of gene expression", J Mol Endocrinol, 29, pp.265~279 (2002)
40. Champigny MJ, "Characterization of the mouse lysosomal sialidase promoter", Gene, 319, pp.177~187 (2003)
41. Lim HS, "Hyaluronic acid induces COX-2 expression via CD44 in orbital fibroblasts from patients with thyroid-associated ophthalmopathy", Invest Ophthalmol Vis Sci, 55, pp.7441~7450 (2014)
42. Han R, "T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1β in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy", Endocrinology, 147, pp.13~19 (2006)
43. Bobowski M, "Estradiol represses the GD3 synthase gene ST8SIA1expression in human breast cancer cells by preventing NFκB binding to ST8SIA1 promoter", PLoS One, 8, pp.e62559~ (2013)

관련 논문AI추천